The ADP test is a blood test that measures how well your platelets clump together when exposed to adenosine diphosphate (ADP), a chemical your body naturally releases at the site of an injury to help form blood clots. It’s one of the most commonly used platelet aggregation tests, ordered to investigate unexplained bleeding problems or to check whether certain blood-thinning medications are working properly.
What the Test Measures
When you cut yourself or damage a blood vessel, your body releases several chemicals that tell platelets to stick together and plug the wound. ADP is one of the most important of these signals. It works by binding to two specific receptors on the surface of platelets. Both receptors need to be activated for normal clotting to occur, but blocking either one is enough to prevent platelets from clumping.
The ADP test isolates this specific pathway. By adding ADP to a sample of your blood in a lab, technicians can watch whether your platelets respond normally, sluggishly, or not at all. This tells your doctor a lot about whether you have a platelet disorder, whether a medication is affecting your clotting, or whether your platelets have an inherited defect in their signaling machinery.
Why Doctors Order It
The ADP test serves two main purposes: diagnosing bleeding disorders and monitoring medications.
For diagnosis, the test helps distinguish between several inherited platelet conditions. In Glanzmann thrombasthenia, a rare genetic disorder, platelets completely fail to aggregate even when exposed to high concentrations of ADP. This total absence of response is a hallmark of the condition. By contrast, in Bernard-Soulier syndrome, platelets aggregate normally with ADP but fail a different test using a substance called ristocetin. Seeing which chemicals trigger clumping and which don’t helps narrow down exactly where the problem lies.
There’s also a category of disorders involving the platelet’s internal amplification system, where granules inside the platelet don’t release their contents properly. In these cases, platelets show impaired aggregation with low concentrations of ADP but can still respond to high concentrations. This pattern can also show up in people who have recently taken aspirin or NSAIDs like ibuprofen, which is why doctors ask you to avoid these medications for at least 10 days before the test.
For medication monitoring, the ADP test is particularly relevant for people taking drugs that block the P2Y12 receptor, one of the two platelet receptors that ADP binds to. Clopidogrel is the most well-known of these medications. Some people don’t respond adequately to clopidogrel, a phenomenon sometimes called clopidogrel resistance, defined as less than a 10% decrease in platelet aggregation compared to pre-treatment levels. Genetic differences can make the drug less effective in certain individuals, and the ADP test can reveal whether platelets are still too reactive despite treatment.
How the Test Works
The most established method is called light transmission aggregometry. A blood sample is drawn and spun gently in a centrifuge to separate out the platelet-rich plasma, the liquid portion of blood packed with platelets. This sample needs to be prepared quickly, ideally within an hour of the blood draw, and must be used within four hours.
The platelet-rich plasma is placed in small tubes with stir bars and warmed for several minutes inside the testing instrument. The lab then adds ADP to the sample and monitors what happens. As platelets clump together, the liquid becomes clearer, allowing more light to pass through. The instrument measures this change in light transmission over about six minutes, producing a curve that shows how quickly and completely the platelets aggregated.
The result is reported as a percentage of maximum aggregation. A separate tube of platelet-poor plasma (spun harder to remove most platelets) serves as the baseline for 100% light transmission.
What Normal and Abnormal Results Look Like
Normal platelet aggregation in response to a standard low dose of ADP (2 micromoles per liter) falls roughly in the range of 55% to 87% maximum aggregation. Results can vary depending on the lab and the concentration of ADP used, so your results will be compared against your lab’s specific reference range.
The pattern of the response matters as much as the number. A normal response produces a stable curve where platelets clump and stay clumped. In P2Y12 receptor defects, aggregation may start but then quickly reverse, producing a characteristic pattern where the curve rises and falls back down. This reversible aggregation is a strong clue pointing toward a problem with that specific receptor. Heterozygous P2Y12 deficiency (carrying one defective copy of the gene) typically shows this reversible pattern at ADP concentrations of 10 micromoles per liter or less.
Complete absence of ADP-induced aggregation, even at very high concentrations, points toward conditions like Glanzmann thrombasthenia, where the final step of platelet-to-platelet binding is broken. In these cases, platelets still change shape normally when exposed to ADP (confirming they received the signal) but simply cannot link together.
Preparing for the Test
The most important preparation step is stopping certain medications well in advance. Aspirin and NSAIDs affect platelet function for days after a single dose, so most labs require you to avoid them for at least 10 days before the test. If you take a prescription blood thinner or antiplatelet drug, your doctor will give specific instructions about whether to continue or pause it, depending on whether the test is being used to diagnose a disorder or to monitor the drug’s effect.
Let your doctor know about any vitamins, supplements, or over-the-counter medications you take, since some of these can also influence platelet behavior. Fasting is not typically required for platelet aggregation testing, but your lab may have its own instructions depending on what other tests are being run alongside it.
Limitations of the Test
While the ADP test is a cornerstone of platelet function testing, it has some practical constraints. The sample must be processed and tested within a narrow time window, making it difficult to run in facilities without on-site specialized equipment. Results can also be affected by the platelet count itself. If your platelet count is very low, the test may not produce reliable results regardless of how well individual platelets function.
For monitoring clopidogrel, several large clinical trials have tried using ADP-based platelet function testing to guide treatment decisions, such as increasing doses or switching medications when test results suggested the drug wasn’t working well enough. These trials have largely failed to show that adjusting treatment based on test results improves patient outcomes, though the reasons are debated. Genetic testing for drug metabolism has emerged as a complementary approach in some cases. The ADP test remains most useful as a diagnostic tool for inherited and acquired platelet disorders rather than as a routine guide for adjusting medication doses.